Showing results (531-540 of 618) with videos related to
Sort By:
Pageof 62
Journal of Gastroenterology and Hepatology|January 11, 2013
Gender-specific association of the interleukin 18 gene with symptomatic gallstone diseaseShou-Chuan Shih, Horng-Woei Yang, Tzu-Yang Chang, et al.Journal of Clinical and Translational Hepatology|March 11, 2026
Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched AnalysisYuan-Hung Kuo, Wei Teng, Yen-Hao Chen, et al.Cancers|July 2, 2021
A Prediction Model for Metachronous Peritoneal Carcinomatosis in Patients with Stage T4 Colon Cancer after Curative ResectionTzong-Yun Tsai, Jeng-Fu You, Yu-Jen Hsu, et al.Heart Rhythm|April 5, 2019
Ten-year ablation outcomes of patients with paroxysmal atrial fibrillation undergoing pulmonary vein isolationWen-Han Cheng, Li-Wei Lo, Yenn-Jiang Lin, et al.Proceedings of the National Academy of Sciences of the United States of America|January 13, 2021
X-ray linear dichroic ptychographyYuan Hung Lo, Jihan Zhou, Arjun Rana, et al.Journal of the American Society of Nephrology : JASN|May 24, 2014
Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injuryYi-Ting Chen, Yu-Ting Chang, Szu-Yu Pan, et al.Journal of the Chinese Medical Association : JCMA|March 13, 2024
Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinomaYuan-Hung Wu, Shu-Huei Shen, Yen-Po Wang, et al.Science Advances|September 27, 2019
Multimodal x-ray and electron microscopy of the Allende meteoriteYuan Hung Lo, Chen-Ting Liao, Jihan Zhou, et al.The Journal of Antimicrobial Chemotherapy|February 16, 2019
A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trialWei-Chen Tai, Chih-Ming Liang, Chung-Mou Kuo, et al.Helicobacter|September 13, 2012
The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot studySeng-Kee Chuah, Wei-Chen Tai, Pin-I Hsu, et al.Pageof 62